Testing effectiveness (Phase 2)Ended earlyNCT03170232
What this trial is testing
A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)
Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 54